< Back to all Team Members

D. Neil Hayes, MD, MPH

Medical Oncologist and Hematologist
Specialty Area
Team Role
Primary Location
7945 Wolf River Boulevard
Germantown, TN 38138
Phone: 901.683.0055

D. Neil Hayes, MD, MPH, has joined as a board certified Medical Oncologist and Hematologist at West Cancer Center and Van Vleet Endowed Professor in the Division of Medical Oncology at the University of Tennessee Health Science Center (UTHSC). An academic leader and clinical expert in the field of oncology, Dr. Hayes joins the West Cancer Center faculty with a dual focus on both his clinical practice and research initiatives.

Titles and Roles

• Medical Oncologist and Hematologist, West Cancer Center
• Scientific Director, UT/West Institute for Cancer Research•Professor, Department of Preventive Health, University of Tennessee Health Science Center
• Van Vleet Endowed Professor, Division of Medical Oncology, UTHSC

Areas of Expertise

• Medical Oncology
• Hematology

Biography

Dr. Hayes joins the West Cancer Center faculty as a physician scientist. Prior to joining the West Cancer Center team, Dr. Hayes served as Co-Leader of the University of North Carolina (UNC) Lineberger Clinical Research Program, Associate Professor in the Division of Hematology/Oncology and the Department of Otolaryngology/Head and Neck Cancer Surgery, and Director of Clinical Bioinformatics at UNC. With a dual focus on both clinical practice and laboratory science, Dr. Hayes dedicates part of his time to research and education at UTHSC, where he also serves a Van Vleet Endowed Professor in the Division of Medical Oncology. In addition to his clinical and research roles, he also serves as Scientific Director of the UT/West Institute for Cancer Research, the non-profit fundraising arm of West Cancer Center. Through this role, he will direct and drive grant funding to lead scientific initiatives for discovery.

Dr. Hayes is a member of many leadership committees, including the of the National Cancer Institute (NCI) Head and Neck Steering Committee’s Metastatic/Recurrent Disease Task Force, the National Co-Chair for the Cancer Genome Atlas’ Data Analysis Subgroup, and the National Co-Chair for the Cancer Genome Atlas’ Head and Neck Cancer. As Dr. Hayes joins our team at West Cancer Center, his enthusiasm for the future dwarfs his accomplishments to date.

Education and Training

• Bachelors of Science, Chemistry, Davidson College, Davidson, North Carolina
• Doctor of Medicine, University of North Carolina, Chapel Hill, North Carolina
• Masters of Public Health, Epidemiology, Harvard School of Public Health, Boston, Massachusetts
• Residency, Internal Medicine, Boston University School of Medicine, Boston, Massachusetts
• Fellowship, Hematology/Oncology, Tufts New England Medical Center, Boston, Massachusetts
• Post-Doctoral Fellowship, Genomics, Dana Farber Cancer Institute, Boston, Massachusetts
• Masters of Science, Clinical Care Research, Tufts New England Medical Center, Boston, Massachusetts

Awards

• American Society for Clinical Investigation, 2013
• 1st Place Clinical/Translational Research Prize: Characteristics Affecting Inter Observer Reproducibility in Morphologic Diagnoses of Non-Small Cell Lung Cancer Subtypes, Lineberger Comprehensive Cancer Center, 2009
• 2nd Place Clinical/Translational Research Prize: p16INK4a Over-Expression is Associated with Improved Outcomes in Young patients with Squamous Cell Cancers of the Oral Tongue, Lineberger Comprehensive Cancer Center, 2009
• Village Pride Award, WCHL, 2008
• Translational Research Prize, Lineberger Comprehensive Cancer Center, 2006
• Clinical and Translational Research Award, Lineberger Comprehensive Cancer Center, 2005

Research

Dr. Hayes pursues a vision of scholarship, service and teaching, centered in the concept of personalized medicine. The foundation of this vision is excellence in clinical care, from which he has started – and grown during his time at the University of North Carolina – one of the most productive clinical trials programs for head and neck cancer in the nation. In parallel, he has developed tissue repositories and data systems that have allowed the lab to make critical observations in cancer, which includes diagnostic tests in the area of lung cancer that carry a provisional patent and a start-up company. Each component of his work has been accompanied by successfully garnered funding – totaling over $40 million – and has included many educational and collaborative opportunities.

Publications/Presentations

To view Dr. Hayes’ most recent publications, click here.